Plain-English translation of NCT04519151 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Neoplasms research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether two medications — and — work better together to treat ovarian cancer that has come back after chemotherapy. You would take as a daily pill and receive through an IV infusion every three weeks. The study wants to see if this combination can help stop the cancer from growing.
Ovarian cancer that returns after chemotherapy is difficult to treat, and doctors are looking for new approaches. This trial exists to find out whether combining these two medications might help patients whose cancer has come back and still responds to platinum-based chemotherapy.
You likely qualify if…
You likely don't qualify if…
You would take as a 20 mg pill by mouth once daily and receive as an IV infusion of 200 mg every three weeks. You would continue this treatment until your cancer progresses, you experience unacceptable side effects, or you complete 35 cycles of the medication. Every 9 weeks, you would have CT scans or MRI to check how well the treatment is working, and you would have blood tests and clinic visits to monitor for side effects.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Israel